2nd Quarter - Report

HOOPER, LUNDY & BOOKMAN, P.C. for ROCHE DIAGNOSTICS CORPORATION

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to clinical diagnostic laboratory services; Issues related to public health emergency preparedness; H.R. 2369 The Verifying Leading-edge IVCT Development Act.

LobbyistCovered position, as disclosed
LISA LAYMAN SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996)

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2369 (118th)

Medical/Disease Research/Clinical Labs MED

H.R. 2369 The Verifying Leading-edge IVCT Development Act.

LobbyistCovered position, as disclosed
LISA LAYMAN SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996)

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2369 (118th)

Medicare/Medicaid MMM

S.1000 / H.R. 1835 Saving Access to Laboratory Services Act (SALSA).

LobbyistCovered position, as disclosed
LISA LAYMAN SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996)

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1835 (118th), S. 1000 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.